"Activist Investor Politan's Influence Drives Masimo Stock Surge and Potential Consumer-Business Separation"
Activist investor Politan Capital, a 9% shareholder in health-tech company Masimo, is planning a second proxy fight to nominate two directors to the board following Masimo's announcement of a potential spinoff of its audio unit. The move comes after the activist's first proxy fight, which resulted in two board seats. Politan's nominees are former Agilent executive Darlene Solomon and former Stryker CFO Bill Jellison, and if successful, the investor would control four of the company's six board seats. Masimo's CEO, Joe Kiani, has been accused of rebuffing the activist's efforts and refusing to provide basic information, leading to the intensification of the proxy fight.
- Activist investor Politan plans second fight at Masimo, sending shares up 5% CNBC
- Masimo Stock Surges After Proposed Spinoff of Consumer Business Investopedia
- Masimo May Look at Joint Venture for Consumer Split, CEO Says The Wall Street Journal
- Masimo Stock Breaks Out On Potential Consumer-Business Separation Investor's Business Daily
- Activist Investor Politan Seeks Two More Board Seats at Masimo Bloomberg
Reading Insights
0
1
2 min
vs 3 min read
78%
479 → 104 words
Want the full story? Read the original article
Read on CNBC